OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
NHF59

NIB Holdings Ltd

Life & Health InsuranceVerified

NIB Holdings Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.28, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium risk, with free cash flow of 69 million AUD and operating cash flow of 165.7 million AUD, but net cash is negative after subtracting total debt. This suggests that while the company generates sufficient cash from operations, it may need to manage its debt obligations carefully to maintain liquidity. In terms of profitability, NIB Holdings Ltd demonstrates a return on equity (ROE) of 17.91% and a return on assets (ROA) of 9.1%, both of which are strong indicators of efficient capital utilization and asset management. These metrics are particularly relevant in the insurance industry, where ROE is a key performance indicator for assessing the effectiveness of equity in generating profits. The company's revenue is primarily concentrated in its core life and health insurance segments, with no significant geographic diversification reported in the available data. This concentration may expose the company to regional economic fluctuations, particularly in Australia and New Zealand, where it operates. Looking ahead, NIB Holdings Ltd is expected to maintain a stable growth trajectory, supported by its strong operating income of 268.9 million AUD and net income of 199 million AUD. Analysts have provided a mean price target of 7.52 AUD, with a median of 7.50 AUD, indicating a generally positive outlook on the company's future performance. The risk assessment for NIB Holdings Ltd highlights a medium liquidity risk and a low dilution risk. The company's key financial flags include a negative net cash position after accounting for total debt, which could impact its ability to meet short-term obligations without additional financing. However, the low dilution risk suggests that the company is not currently under pressure to issue new shares, which helps preserve shareholder value. Recent events and filings do not indicate any significant changes in the company's strategic direction or financial health. The company's capital expenditure of -53.6 million AUD suggests a reduction in capital spending, which may be a strategic move to conserve cash and improve liquidity.

30-day price · NHF+0.03 (+0.4%)
Low$6.34High$6.98Close$6.78As of26 May, 00:00 UTC
Profile
CompanyNIB Holdings Ltd
TickerNHF.AX
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. NIB Holdings Ltd provides life and health insurance products and services in Australia and New Zealand, generating revenue primarily through premium income and investment returns.

Classification. NIB Holdings Ltd is classified under the Life & Health Insurance industry within the Financials sector, with a confidence level of 0.92 based on verified market data.

NIB Holdings Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.28, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium risk, with free cash flow of 69 million AUD and operating cash flow of 165.7 million AUD, but net cash is negative after subtracting total debt. This suggests that while the company generates sufficient cash from operations, it may need to manage its debt obligations carefully to maintain liquidity. In terms of profitability, NIB Holdings Ltd demonstrates a return on equity (ROE) of 17.91% and a return on assets (ROA) of 9.1%, both of which are strong indicators of efficient capital utilization and asset management. These metrics are particularly relevant in the insurance industry, where ROE is a key performance indicator for assessing the effectiveness of equity in generating profits. The company's revenue is primarily concentrated in its core life and health insurance segments, with no significant geographic diversification reported in the available data. This concentration may expose the company to regional economic fluctuations, particularly in Australia and New Zealand, where it operates. Looking ahead, NIB Holdings Ltd is expected to maintain a stable growth trajectory, supported by its strong operating income of 268.9 million AUD and net income of 199 million AUD. Analysts have provided a mean price target of 7.52 AUD, with a median of 7.50 AUD, indicating a generally positive outlook on the company's future performance. The risk assessment for NIB Holdings Ltd highlights a medium liquidity risk and a low dilution risk. The company's key financial flags include a negative net cash position after accounting for total debt, which could impact its ability to meet short-term obligations without additional financing. However, the low dilution risk suggests that the company is not currently under pressure to issue new shares, which helps preserve shareholder value. Recent events and filings do not indicate any significant changes in the company's strategic direction or financial health. The company's capital expenditure of -53.6 million AUD suggests a reduction in capital spending, which may be a strategic move to conserve cash and improve liquidity.
Key takeaways
  • NIB Holdings Ltd maintains a strong ROE of 17.91% and ROA of 9.1%, indicating efficient capital and asset utilization.
  • The company's liquidity position is characterized as medium risk, with a negative net cash position after subtracting total debt.
  • NIB Holdings Ltd's revenue is primarily concentrated in its core life and health insurance segments, with no significant geographic diversification.
  • Analysts have provided a generally positive outlook, with a mean price target of 7.52 AUD.
  • The company's low dilution risk suggests that it is not currently under pressure to issue new shares, preserving shareholder value.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income$268.9M
Net income$199.0M
R&D
SG&A
D&A
SBC
Operating cash flow$165.7M
CapEx-$53.6M
Free cash flow$69.0M
Total assets$2.19B
Total liabilities$1.08B
Total equity$1.11B
Cash & equivalents$4.4M
Long-term debt$310.2M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.11B
Net cash-$305.8M
Current ratio
Debt/Equity0.3
ROA9.1%
ROE17.9%
Cash conversion83.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricNHFActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity28.0%27.5% medp25 4.7% · p75 66.5%above median
Observations
IR observations
Mean price target7.52 AUD
Median price target7.50 AUD
High price target8.90 AUD
Low price target6.10 AUD
Mean recommendation2.30 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count4.00
Hold count3.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate0.42 AUD
Last actual EPS0.47 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-22 17:40 UTC#cb5314dc
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 17:58 UTCJob: f8231a1b